nt 776, T to C, Leu to Pro
Fourty-four of 389 patients with VHL (between 1988-1999) screened positive for pancreatic neuroendocrine tumours (PNETs) either by pathologic analysis of tissue specimens or by characteristic radiographic appearance on CT and MRI. VHL gene germline mutations were determined by quantitative Southern blotting to detect deletions of the gene and gene rearrangements as well as complete gene sequencing. Patient 44 (39 year old male) was found to harbour the c.563T>C mutation in the VHL gene (stated as 776 T to C in the paper which used the Latif sequence as reference) resulting in a Leu to protein change at position 188. The patient presented with two pathologic pancreatic neuroendocrine tumors. ACMG evidence codes: 'PP4' since the patient presents phenotypes highly specific for a disease with a single genetic etiology.